Access

Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in genomics, we have the obligation to drive down the cost of sequencing, expand access to diagnostics technology, and increase the diversity of genomics data to realize health equity for billions of people around the world.

Videos from this campaign

Stephanie Lheureux, MD, PhD,Princess Margaret Cancer Centre (PMCC).
Illumina Booth at UK Festival of Genomics & Biodata

Content from this campaign

Health & Healthcare

Illumina Leads the Way With Its Steps Against Cancer Campaign
Illumina employees have been showing their commitment to early cancer detection and advancing research and treatment by getting involved in the company’s recently concluded Steps Against Cancer campaign.

Health & Healthcare

The Emerging Population Genomics Revolution
The Human Genome Project described the first (almost) complete reference genome, but it didn’t say much about human variation. For that, scientists had to conduct massive population genomics (pop gen) studies, sequencing millions of people.

Health & Healthcare

Washington, DC’s Secret Weapon for RSV Surveillance
The Next-Generation Sequencing Core in the Washington, DC, Public Health Laboratory (PHL) has a critical job: pathogen surveillance for the nation’s capital. A team of scientists is trying to understand the molecular underpinnings that drive foodborne illnesses.

Health & Healthcare

Evidence Supports Sequencing As First-Line Rare Disease Diagnostic
A recent literature review, published in the Nature journal Genomic Medicine, showed that short-read genomic sequencing (GS) reduces the time it takes to diagnose and treat pediatric patients who may have a rare genetic condition.

Health & Healthcare

Video: Merging Discovery With Clinical Care at Ontario Institute for Cancer Research
In the middle of downtown Toronto, surrounded by major universities and hospitals, the Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care.

Health & Healthcare

What the Diagnostic Odyssey Looks Like—And How We Can End It
People unfamiliar with the world of rare diseases might assume that someone with a genetic disorder received their diagnosis at birth. Unfortunately, this is almost never the case.

Health & Healthcare

Illumina and Pillar Biosciences Partner To Improve Access to Personalized Cancer Treatment Options
Illumina and Pillar Biosciences Inc., the pioneers of Decision Medicine™, announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.

Diversity & Inclusion

Bridging the Diagnosis Gap for Canada’s Indigenous Children
The United Nations Declaration on the Rights of Indigenous Peoples asserts “the right to access, without any discrimination, to all social and health services.” When the 159-member General Assembly adopted the declaration in 2007, only four members voted against it.

Health & Healthcare

The African Continent Ramps Up Efforts To Crack the Code on Outbreaks
On a recent afternoon in Nairobi, Kenya, about two dozen scientists gathered, peering at a screen that to the untrained eye looked like gibberish — rows of letters but no coherent words.

Health & Healthcare

ACEGID and Illumina to Increase Africa’s Genomics Capacity through Establishment of a Joint Training Academy
The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, announced that it will collaborate with Illumina on a joint workforce development training academy, with the objective of increasing Africa’s genomics capacity.
Illumina logo

More from Illumina

  1. Business
    At Illumina, the faster we can innovate, the more lives we can help save. As a genomics pioneer, we have proven through focused and continued...

  2. People
    Harnessing the world’s best talent and giving them the opportunity to thrive allows us to make world-changing leaps in human health and beyond. Our...

  3. Access
    Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in...

  4. Community
    By sharing our time, talent, and technology, we aim to inspire, support, and empower our communities, our employees, and the next generation.

  5. Environment
    We are committed to integrating environmental stewardship into the way we operate. We recognize the importance of the environment in creating a...

  6. Operating Responsibly
    Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we...